Latest stories

  • in

    Zydus Lifesciences bags USFDA nod for Azithromycin Tablets to treat certain bacterial infections

    Zydus Lifesciences bags USFDA nod for Azithromycin Tablets to treat certain bacterial infections

    Ahmedabad: Drugmaker, Zydus Lifesciences Limited, has announced that the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Azithromycin Tablets USP, 500 mg (USRLD: Zithromax Tablets). Azithromycin is indicated to treat certain bacterial infections such as bronchitis, pneumonia, sexually transmitted diseases (STD), infections of the ears, […] More

  • in

    Azithromycin improves Meibomian gland dysfunction with lesser GI side effects

    A recent study by Phit Upaphong and colleagues shows that, azithromycin and doxycycline have similar impacts on the meibomian gland dysfunction (MGD) score and Ocular Surface Disease Index (OSDI) score at both follow-up intervals. The findings of this study were published in the Journal of American Medical Association. Oral doxycycline takes a 6-week course of […] More